Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Porter

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Pediatrics|March 30, 2024
Defining the Denominator for Measuring Quality of End-of-Life Care in Children with Cancer: Results of a Nominal Group TechniqueEmily E Johnston, Raba Tefera, Prasanna Ananth, et al.
Eclinicalmedicine|March 2, 2026
Advancing child health through applied qualitative researchSara Malone, Gemma Bryan, Erica Carlisle, et al.
Journal of Pain and Symptom Management|April 5, 2025
A Qualitative Study of CMC Caregivers' Perspectives about their Emotional Well-BeingJustin A Yu, Amy Porter, Jori Bogetz, et al.
Molecular Ecology|August 17, 2022
Isolated Grauer's gorilla populations differ in diet and gut microbiomeAlice Michel, Riana Minocher, Peter-Philip Niehoff, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2012
Discovery of selective biaryl ethers as PDE10A inhibitors: improvement in potency and mitigation of Pgp-mediated effluxRobert M Rzasa, Essa Hu, Shannon Rumfelt, et al.
Journal of Medicinal Chemistry|October 10, 2013
Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A)Essa Hu, Roxanne K Kunz, Ning Chen, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Journal of Medicinal Chemistry|May 3, 2012
Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracerEssa Hu, Ji Ma, Christopher Biorn, et al.
Blood|October 28, 2018
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammationSebastien Jacquelin, Jasmin Straube, Leanne Cooper, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|March 30, 2024
Defining the Denominator for Measuring Quality of End-of-Life Care in Children with Cancer: Results of a Nominal Group TechniqueEmily E Johnston, Raba Tefera, Prasanna Ananth, et al.
Eclinicalmedicine|March 2, 2026
Advancing child health through applied qualitative researchSara Malone, Gemma Bryan, Erica Carlisle, et al.
Journal of Pain and Symptom Management|April 5, 2025
A Qualitative Study of CMC Caregivers' Perspectives about their Emotional Well-BeingJustin A Yu, Amy Porter, Jori Bogetz, et al.
Molecular Ecology|August 17, 2022
Isolated Grauer's gorilla populations differ in diet and gut microbiomeAlice Michel, Riana Minocher, Peter-Philip Niehoff, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2012
Discovery of selective biaryl ethers as PDE10A inhibitors: improvement in potency and mitigation of Pgp-mediated effluxRobert M Rzasa, Essa Hu, Shannon Rumfelt, et al.
Journal of Medicinal Chemistry|October 10, 2013
Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A)Essa Hu, Roxanne K Kunz, Ning Chen, et al.
Nature Communications|April 14, 2023
Oncogenic drivers dictate immune control of acute myeloid leukemiaRebecca J Austin, Jasmin Straube, Rohit Halder, et al.
Journal of Medicinal Chemistry|May 3, 2012
Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracerEssa Hu, Ji Ma, Christopher Biorn, et al.
Blood|October 28, 2018
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammationSebastien Jacquelin, Jasmin Straube, Leanne Cooper, et al.
Journal of Medicinal Chemistry|July 26, 2014
Discovery of clinical candidate 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), a potent, selective, and efficacious inhibitor of phosphodiesterase 10A (PDE10A)Essa Hu, Ning Chen, Matthew P Bourbeau, et al.
Pageof 3